A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
PHASE3
This trial is a registrational Phase III, randomized, open-label, multicent...
Status
Not Yet Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC
PHASE2
This trial is a multicenter, open-label, Phase II clinical study to explore...
Status
Recruiting
Location
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan
PHASE3
This trial is a registrational Phase III, randomized, open-label, multicent...
A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast Cancer
PHASE3
This trial is a registrational Phase III, randomized, open-label, multicent...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
A Study of BL-M07D1 Combination Therapy in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
PHASE2
This study is a multicenter, open-label, phase II clinical study to explore...